A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting. ... Read More The post Dr Boreham’s Crucible: A rival may be circling, ...

Splose has added $46 million to its funding pot and will seek to deepen its presence in the United Kingdom’s allied health ...

In 2021, a unit of healthcare giant Johnson & Johnson announced “a leap forward”: It had added artificial intelligence to a ...

Even in the best-case scenario, it’s incredibly disruptive. And this is where you’ve been quoted saying that A.I. will disrupt 50 percent of entry-level white-collar jobs. On a five-year time horizon, ...

Even the most technically flawless financial plan can fail—because markets aren’t the real wildcard. Behavior is. As growth ...

As AI job losses rise in the professional sector, many are switching to more traditional trades. But how do they feel about accepting lower pay – and giving up a dream career?

The introduction of AI to the operating theater doesn’t always work out as optimists, or the FDA, might expect.

Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care. Medically integrated dispensing (MID) has the ...

Yosi Amram draws on military leadership, startups, and psychology to help CEOs develop spiritual intelligence and redefine ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...

Couples together for decades reflect on the arc of their relationships, including the tough times and the everyday rituals that sustained them ...

Order intake increased by 8% to SEK 330 M (305)Net sales increased by 16% to SEK 375 M (323), with organic growth of 28%Operating profit (EBIT) strengthened by 25% ...